États-Unis · Plateformes & données · MarketBeat
Cellebrite DI Ltd. (NASDAQ:CLBT) Stock Has Consensus Price Target of $14.75

Résumé détaillé
Cellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) has earned an average recommendation of "Moderate Buy" from the five research firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating and four have given a buy rating to the company
MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)



